Compare ELME & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELME | EDAP |
|---|---|---|
| Founded | 1960 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.2M | 163.4M |
| IPO Year | 1994 | 1998 |
| Metric | ELME | EDAP |
|---|---|---|
| Price | $2.15 | $4.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $12.67 | $8.50 |
| AVG Volume (30 Days) | ★ 1.1M | 59.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 33.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $206,360,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.10 | $1.21 |
| 52 Week High | $17.68 | $5.05 |
| Indicator | ELME | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 13.05 | 48.03 |
| Support Level | $2.10 | $3.89 |
| Resistance Level | $2.26 | $4.24 |
| Average True Range (ATR) | 0.03 | 0.33 |
| MACD | 0.24 | -0.05 |
| Stochastic Oscillator | 34.93 | 43.06 |
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.